Akerna Acquires Remaining 20% Stake in Solo Sciences

Akerna (NASDAQ: KERN), a software and compliance tech provider for the cannabis industry, has agreed to acquire the remaining 20% of Solo Sciences inc.

The closing of the options is expected to take place on July 31.

Solo Sciences‘ patent technology guarantees users instant authentication of packaged products by giving each …

Full story available on Benzinga.com

More Akerna Acquires Remaining 20% Stake in Solo Sciences